People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neoprobe Corp | — | Biotechnology | Series A | $14.0M | $506.1M | 2010 |
Reuven C. Avital at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Reuven C. Avital on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gordon A. Troup | 1 | 1 |
| Douglas L. Rash | 1 | 1 |
| Fred B. Miller | 1 | 1 |
| J. Frank Whitley, Jr. | 1 | 1 |
| Anthony K. Blair | 1 | 1 |
| Brent L. Larson | 1 | 1 |
| Rodger A. Brown | 1 | 1 |
| Carl J. Aschinger, Jr. | 1 | 1 |
| Owen E. Johnson | 1 | 1 |
| Frederick O. Cope | 1 | 1 |
| Kirby I. Bland | 1 | 1 |
| David C. Bupp | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.